Revenues are too small at this point for management to consider any buyout. I am looking for more expansion through organic growth and acquisition. They just started a strategic partnership with Northwestern Univ. and my guess is that is a foot in the door in the Chicagoland area and a new independent lab will eventually open there. We need a presence in TX and greater exposure in the Northeast as well. If these come to pass, we will be much bigger, have revenues in the $250-350 million/yr range and THEN will be a buyout target.
Looks like the company is hitting on all cylinders except profit. With this level of growth, the lack of profitability might be forgiven, but the company is pushing it. The losses clearly impact shareholder value and it appears that the business model is 1990's era.
Yes, that would be the next logical step. Mgmt is quite good at making sure they run their labs up to a capacity that will require this kind of growth. They are in line for over $100 million in revenue for the next 4 quarters, and they will need more capacity within that next 4 quarters.
Just curious, are you speculating, do you smell something in the air, or are you on to something that may develop? I bought a very modest amount, something like a side bet that they might actually be able to have a commercial success via NEO, all table money and nothing that I would miss if it went away, so it sits on the table.